In summary, SP has an ameliorative effect on hepatic fibrosis, probably by inhibiting the activation of hepatic stellate cells, reducing the synthesis of extracellular matrix by down-regulated the protein expression of toll like receptor 4 (TLR4) and nuclear factor-K b (NF-κB) p65. This evidence concerns the gene NFKB1 and Hepatic fibrosis.